Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.
暂无分享，去创建一个
J. Sakamoto | Y. Miyoshi | T. Taguchi | N. Masuda | Toshikazu Ito | S. Morita | J. Tsurutani | T. Arai | H. Kawajiri | T. Takashima | K. Yoshidome | T. Nakayama | S. Kamigaki | T. Doi | K. Miyauchi | Y. Komoike